Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03516513 · ClinicalTrials.gov registry record · NA

Participatory Design of Electronic Health Record Tools for Problem Solving Therapy

A NA study, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
24
Enrollment target

NCT03516513: Completed NA study, sponsored by University of Washington.

NCT03516513 is a NA study that has completed, run by University of Washington. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03516513, a NA study, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target

Study Summary

Problem Solving Therapy for Primary Care (PST-PC) is an evidence based psychosocial intervention (EBPI) for use in primary care settings, with more than 100 clinical trials. Despite its proven efficacy we have found that implementation of PST-PC is complicated, resulting in rapid program drift (deviation from protocol with associated loss of efficacy), among practitioners following completion of training. Many studied have shown that program drift is not uncommon in the implementation of EBPIs and can be mitigated through on-going decision support and supervision. Unfortunately, decision support and supervisors of EBPIs are not widely available in low-resourced primary care clinics. We will address this problem by creating decision support tools to be integrated into electronic health records. Because these tools are deemed by many practitioners in other fields to be burdensome, we will explicitly involve active input on the content, design and function of these support tools. Outcomes may include electronic dashboards for panel management, automated suggestions for application of PST-PC elements based on patient reported outcomes or integration of automated patient tracking, and support of patient engagement. We hypothesize that enhanced decision support (target mechanism) will sustain quality delivery of PST-PC, which in turn will improve patient reported outcomes.

Primary Outcome

The Acceptability of Intervention Measure is a four item measure of intervention acceptability, where each item is rated on a 1-5 scale, with 1 = not at all acceptable and 5 = very acceptable. Total scores depicted here are mean item scores and therefore the minimum and maximum values are 1 and 5. Higher scores mean more acceptable.

Interventions

  • BEHAVIORAL Problem Solving Therapy as Usual
  • BEHAVIORAL Assisted Problem Solving Therapy

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2020-01-30
Est. Completion 2023-04-30
Phase NA
University of Washington

1,048 total trials

What the finished NCT03516513 record still lists

NCT03516513 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Problem Solving Therapy as Usual is the first listed.

NCT03516513 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03516513 about?

NCT03516513 is a clinical study titled "Participatory Design of Electronic Health Record Tools for Problem Solving Therapy". Problem Solving Therapy for Primary Care (PST-PC) is an evidence based psychosocial intervention (EBPI) for use in primary care settings, with more than 100 clinical trials. Despite its proven efficacy we have found that implementation of PST-PC is complicated, resulting in rapid program drift (dev...

What is the current status of trial NCT03516513?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2020-01-30. Estimated completion is 2023-04-30.

What interventions are being tested in trial NCT03516513?

The interventions under investigation include: Problem Solving Therapy as Usual (BEHAVIORAL), Assisted Problem Solving Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT03516513?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03516513's enrollment target sits among peer trials

24 1736th of 2000 higher than 246 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03516513, the US trial registry maintained by the National Library of Medicine. NCT03516513 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.